Workflow
Sirui(688102)
icon
Search documents
斯瑞新材(688102) - 2023 Q1 - 季度财报
2023-04-25 16:00
Financial Performance - The company's operating revenue for Q1 2023 was CNY 251,372,240.85, representing a year-on-year increase of 5.15%[4] - The net profit attributable to shareholders decreased by 30.75% to CNY 21,642,300.48 compared to the same period last year[4] - The net profit after deducting non-recurring gains and losses increased by 61.31% to CNY 18,702,191.50, driven by growth in various business segments and an increase in high-margin export sales[8] - Total revenue from operating activities in Q1 2023 was CNY 253,533,651.85, up from CNY 204,279,328.80 in Q1 2022, representing an increase of 24.1%[22] - The company reported a total comprehensive income of CNY 21,381,125.85 for Q1 2023, down from CNY 31,025,144.29 in Q1 2022, reflecting a decrease of 30.9%[19] - The company’s total profit for Q1 2023 was CNY 23,216,692.23, a decrease of 31.2% from CNY 33,794,287.20 in Q1 2022[22] Cash Flow and Investments - The company's cash flow from operating activities was negative at CNY -3,914,208.31, an improvement of CNY 74,078,100 compared to the previous year's Q1[8] - The net cash flow from operating activities for Q1 2023 was negative CNY 3,914,208.31, an improvement from negative CNY 77,992,262.80 in Q1 2022[22] - The company incurred a total investment cash outflow of CNY 82,895,489.18 in Q1 2023, compared to CNY 31,091,473.93 in Q1 2022, indicating a significant increase in investment activities[24] Research and Development - Research and development expenses totaled CNY 12,108,028.44, which is 4.82% of operating revenue, an increase of 1.66 percentage points year-on-year[5] - Research and development expenses increased significantly to CNY 12,108,028.44 in Q1 2023, compared to CNY 3,976,571.16 in Q1 2022, marking a growth of 204.1%[22] Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,529,293,347.21, reflecting a 2.15% increase from the end of the previous year[5] - Total assets reached CNY 1,529,293,347.21, an increase from CNY 1,497,113,659.06 at the end of 2022, representing a growth of 2.15%[15] - Total liabilities amounted to CNY 493,942,190.63, slightly up from CNY 486,691,206.88 at the end of 2022, indicating an increase of 1.03%[15] - The company's equity attributable to shareholders increased to CNY 1,016,276,146.92 from CNY 993,829,737.89, reflecting a growth of 2.25%[15] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 5,056[10] - The basic and diluted earnings per share were both CNY 0.0541, a decrease of 37.67% year-on-year[4] - The basic and diluted earnings per share for Q1 2023 were CNY 0.0541, down from CNY 0.0868 in Q1 2022, a decrease of 37.5%[19] Financial Ratios - The weighted average return on net assets decreased to 2.15%, down 0.89 percentage points from the previous year[5] - Financial expenses for Q1 2023 were CNY 3,077,278.33, a decrease from CNY 5,587,455.36 in Q1 2022, reflecting a reduction of 45.0%[22] Changes in Assets - The company's cash and cash equivalents decreased to CNY 89,020,861.26 as of March 31, 2023, down from CNY 131,157,856.19 at the end of 2022, representing a decline of 32.19%[13] - Accounts receivable increased to CNY 240,810,304.01 from CNY 220,566,138.12, marking a rise of 9.16%[13] - Inventory rose to CNY 236,213,034.42, compared to CNY 209,599,721.45 at the end of 2022, indicating an increase of 12.68%[13] - Non-current assets totaled CNY 843,661,787.27 as of March 31, 2023, up from CNY 798,691,153.17 at the end of 2022, reflecting a growth of 5.63%[14] - Short-term borrowings rose to CNY 103,756,704.34 from CNY 64,359,087.17, marking an increase of 61.36%[14]
斯瑞新材(688102) - 2022 Q4 - 年度财报
2023-04-25 16:00
Financial Performance - The company's operating revenue for 2022 was CNY 993,605,178, representing a 2.61% increase compared to CNY 968,292,220 in 2021[22]. - The net profit attributable to shareholders for 2022 was CNY 78,014,942.93, a 23.13% increase from CNY 63,362,228.68 in 2021[23]. - The net cash flow from operating activities decreased by 29.54% to CNY 51,461,450.10 in 2022, down from CNY 73,036,334.56 in 2021[23]. - The total assets of the company at the end of 2022 were CNY 1,497,113,659.06, a 16.94% increase from CNY 1,280,194,077.20 at the end of 2021[23]. - The net assets attributable to shareholders increased by 69.35% to CNY 993,829,737.89 at the end of 2022, compared to CNY 586,850,590.01 at the end of 2021[23]. - The company's revenue for 2022 increased by 2.61% compared to the previous year, driven by significant growth in high-strength and high-conductivity copper alloy products and liquid rocket engine thrust chamber products[25]. - Net profit attributable to shareholders increased by 23.13% year-on-year, primarily due to an increase in government subsidies received during the period[25]. - The net profit after deducting non-recurring gains and losses grew by 5.23%, supported by business growth across various segments and reduced financing costs[26]. - The overall operating income was 926,852,375.76 RMB, with a year-on-year increase of 4.86%, while the operating cost was 744,874,792.51 RMB, reflecting a year-on-year increase of 5.37%[114]. - The gross profit margin for the non-ferrous metal segment was 19.60%, a decrease of 0.45 percentage points compared to the previous year[114]. Research and Development - The company is focused on developing new technologies and products in the fields of medical imaging and advanced materials[15]. - The company has invested in R&D for advanced materials, including copper-chromium and copper-tungsten products, to meet market demands[14]. - The company's R&D expenditure as a percentage of operating income rose to 5.19%, an increase of 0.99 percentage points from the previous year[24]. - The company invested 516.13 million RMB in R&D, marking a 27% increase compared to the previous year[39]. - The company has filed 71 new invention patents, bringing the total to 218 authorized invention patents[39]. - The company has achieved large-scale industrialization of key technologies, supplying major clients such as GE and Siemens[96]. - The company has established a provincial advanced copper alloy innovation center to integrate social and technological resources for development[97]. - The company has signed joint R&D agreements with clients to address industry challenges and drive innovation[97]. - The company is actively involved in national major special research projects, enhancing its technological capabilities[97]. - The company has made significant breakthroughs in high voltage and large current contact products, developing copper-chromium contacts for 126kV and 252kV vacuum switches, positioning itself to capture market opportunities in the vacuum switch sector[58]. Market Expansion and Strategy - The company plans to expand its market presence and explore potential mergers and acquisitions to enhance growth opportunities[15]. - The company actively expanded into international markets, resulting in a significant increase in export revenue[25]. - The company is expanding its market presence in the U.S. and Europe while ensuring a self-controlled supply chain for key components in the domestic CT equipment market[41]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million RMB allocated for potential deals[173]. - The company plans to enter two new international markets by Q3 2023, aiming for a 5% market share in each[173]. - The company aims to achieve a market share of over 50% globally in its niche materials sectors, supported by an innovation strategy targeting to hold over 50% of new patents worldwide[148]. Corporate Governance - The company has received a standard unqualified audit report from its accounting firm, ensuring the accuracy and completeness of the financial report[5]. - The company has confirmed that there are no governance special arrangements or significant matters applicable[8]. - The company has established a dedicated team for investor relations, actively engaging with shareholders to protect their rights[159]. - The board consists of 9 members, including 3 independent directors, ensuring a balanced governance structure[157]. - The company adheres to information disclosure obligations, ensuring transparency and fairness in communication with shareholders[159]. - The company has implemented a rigorous training program for directors to enhance governance practices[157]. - The company has established specialized committees under the board, including audit, nomination, compensation, and strategy committees[187]. Financial Management - The company plans to distribute a cash dividend of RMB 0.80 per 10 shares, totaling approximately RMB 32,000,800 (including tax) for the 2022 fiscal year[6]. - The company intends to increase its total share capital from 400,010,000 shares to 560,014,000 shares by issuing 4 new shares for every 10 shares held, resulting in a total of 160,004,000 new shares[6]. - The company has a cash dividend policy that has not been adjusted during the reporting period, ensuring stability and protection for shareholders[197]. - The company reported a total investment of RMB 401,611,828.82 in 2022, representing a 185.60% increase compared to RMB 140,619,392.86 in the previous year[139]. - The company raised a total of RMB 419,304,800.00 from its IPO on March 16, 2022, with a net amount of RMB 356,910,828.82 after deducting issuance costs[139]. - The company has a total of RMB 32,661,905.20 in restricted assets, including cash and fixed assets, due to guarantees and collateral for loans[136]. Operational Challenges - The company faced challenges from a decline in demand in the consumer electronics sector, impacting sales of high-strength and high-conductivity copper alloy materials[25]. - The company is exposed to risks from fluctuations in raw material prices, particularly copper, which could adversely affect its financial performance[102]. - The company faces risks related to technology upgrades and potential R&D failures, which could impact its competitive advantage[99]. - The company reported a decrease in sales revenue for high-strength and high-conductivity copper alloy materials by 8.51%, primarily due to a decline in demand from the consumer electronics sector[116]. - The production of high-strength high-conductivity copper alloy materials and high-performance metal chromium powder showed significant discrepancies between production and sales, primarily due to the inclusion of semi-finished products for internal processing[119]. Employee Management - The company has established a comprehensive performance evaluation system for employees, focusing on various metrics including skill levels and work efficiency[194]. - The company has a training plan in place to ensure employee skills meet strategic development needs, utilizing diverse training methods[195]. - The number of R&D personnel decreased to 79, accounting for 6.70% of the total workforce, down from 81 and 7.27% respectively[93]. - Total compensation for R&D personnel increased to 1,150.24 million, with an average salary of 14.56 million, compared to 1,104.52 million and 13.64 million in the previous period[93]. Future Outlook - The company has set ambitious performance guidance for the upcoming year, aiming for a revenue growth of at least 15%[170]. - The management team emphasized the importance of quality management and operational efficiency in driving future growth[170]. - The company is committed to maintaining high standards of corporate governance and transparency in its operations[170]. - The company plans to establish a production capacity for 100 sets of thrust chamber products by the end of 2023, focusing on the aerospace industry[152].
斯瑞新材(688102) - 投资者关系活动记录表(2022年陕西辖区上市公司投资者集体接待日暨2021年度业绩说明会)
2022-11-19 01:24
证券代码:688102 证券简称:斯瑞新材 陕西斯瑞新材料股份有限公司 投资者关系活动记录表 (2022 年陕西辖区上市公司投资者集体接待日 暨 2021 年度业绩说明会) 编号:2022-001 | --- | --- | --- | --- | --- | --- | |-------------------------|-------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | ☐ 特定对象调研 | ☐ 分析师会议 | | | | | 投资者关系 | ☐ 媒体采访 | 业绩说明会 | | | | | 活动类别 | ☐新闻发布会 | ☐路演活动 | | | | | | ☐ 现场参观 | | | | | | | ☐ | 其他(请文字说明其他活动内容 ...
斯瑞新材(688102) - 2022年5月投资者关系活动记录表2022-002
2022-11-17 15:08
证券代码:688102 证券简称:斯瑞新材 编号:2022-002 陕西斯瑞新材料股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-------------------------|---------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | 特定对象调研 | ☐ 分析师会议 | | | ☐ 媒体采访 | ☐ 业绩说明会 | | 投资者关系 活动类别 | ☐ 新闻发布会 | ☐ 路演活动 | | | ☐ 现场参观 | | | | ☐ | 其他(请文字说明其他活动内容) | | 形式 ...
斯瑞新材(688102) - 2021 Q4 - 年度财报
2022-04-24 16:00
Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2021, representing a year-on-year growth of 15%[20]. - The company's operating revenue for 2021 was CNY 968,292,220.49, representing a 42.26% increase compared to 2020[32]. - Net profit attributable to shareholders for 2021 was CNY 63,362,228.68, up 21.60% year-over-year[32]. - The net profit after deducting non-recurring gains and losses was CNY 50,025,341.45, reflecting a 20.56% increase from the previous year[32]. - The basic earnings per share for 2021 was CNY 0.1760, a 21.63% increase from 2020[33]. - The company achieved a total operating revenue of CNY 968.29 million in 2021, representing a year-on-year growth of 42.26%[178]. - The net profit attributable to shareholders was CNY 63.36 million, an increase of 21.60% compared to the previous year[178]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 0.80 CNY per 10 shares, totaling 32,000,800 CNY (including tax) to all shareholders[6]. - The board of directors has approved the profit distribution plan for the fiscal year 2021 on April 21, 2022[6]. Audit and Governance - The company has received a standard unqualified audit report from its accounting firm[6]. - All directors have confirmed the authenticity, accuracy, and completeness of the annual report[6]. - The company has not disclosed any special arrangements for corporate governance[6]. Research and Development - Investment in R&D increased by 30% to RMB 150 million, focusing on advanced materials and technologies[20]. - The R&D expenditure as a percentage of operating revenue increased to 4.20%, up 0.93 percentage points from the previous year[33]. - R&D investment totaled ¥40,714,174.03, representing an 82.75% increase compared to the previous year, with R&D expenses accounting for 4.20% of operating revenue[122]. - The company has established technical cooperation with several institutions, including Xi'an Jiaotong University and the Chinese Academy of Sciences, to enhance its R&D capabilities[159]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a revenue contribution of 20% from this region by 2023[20]. - The company is exploring potential mergers and acquisitions to enhance its product portfolio and market reach, with a budget of RMB 500 million allocated for this purpose[20]. - The company is actively entering new markets, including nuclear magnetic resonance and medical accelerator components, to diversify its product offerings[53]. - The company aims to strengthen its core competitiveness through a multi-dimensional approach, including technology management and innovation[54]. Risks and Challenges - The company has described potential risks in the "Management Discussion and Analysis" section of the report[6]. - The company faces risks related to the inability to commercialize new technologies or products, which could lead to unfulfilled R&D investments[160]. - The ongoing COVID-19 pandemic has introduced uncertainties that may impact the company's production continuity and operational stability[163]. - The company faces risks from international political and economic changes, particularly affecting its export markets[177]. Production and Capacity - The company initiated a five-year capacity expansion plan, targeting an annual production capacity of 12 million copper-chromium contacts by 2021[49]. - A new production line for high-performance metal chromium powder with an annual capacity of 2,000 tons was launched during the reporting period[52]. - The company plans to add 40,000 tons of copper-iron and chromium-zirconium copper alloy production capacity over the next six years, with the first phase already under construction[162]. Product Development and Innovation - New product development includes the launch of a high-performance copper alloy material, expected to generate an additional RMB 200 million in revenue in 2022[20]. - The company has developed a new generation of copper-iron alloy materials, which have broad application prospects in 5G mobile phone heat dissipation and electromagnetic shielding, showcasing its advanced material synthesis technology[72]. - The company has developed a series of advanced core technologies in high-strength and high-conductivity copper alloy materials, including 9 authorized invention patents and 3 pending patents for traction motor end ring and conductor manufacturing technology[91]. Supply Chain and Procurement - The company’s procurement model combines centralized supply chain management with autonomous procurement by various business units to ensure supply chain stability[62]. - The company has established a digital supply chain platform that enhances procurement efficiency and reduces costs, significantly improving supply chain collaboration and management experience[155]. Awards and Recognition - The company has been recognized with the Shaanxi Quality Award in 2021, highlighting its commitment to quality and innovation in manufacturing[111]. - The company has received multiple prestigious awards, including the National Science and Technology Progress Second Prize and the China Patent Excellence Award, with a total of 149 authorized invention patents by the end of the reporting period[146].